Unknown

Dataset Information

0

Cytosolic 5'-Nucleotidase II Silencing in a Human Lung Carcinoma Cell Line Opposes Cancer Phenotype with a Concomitant Increase in p53 Phosphorylation.


ABSTRACT: Purine homeostasis is maintained by a purine cycle in which the regulated member is a cytosolic 5'-nucleotidase II (cN-II) hydrolyzing IMP and GMP. Its expression is particularly high in proliferating cells, indeed high cN-II activity or expression in hematological malignancy has been associated to poor prognosis and chemoresistance. Therefore, a strong interest has grown in developing cN-II inhibitors, as potential drugs alone or in combination with other compounds. As a model to study the effect of cN-II inhibition we utilized a lung carcinoma cell line (A549) in which the enzyme was partially silenced and its low activity conformation was stabilized through incubation with 2-deoxyglucose. We measured nucleotide content, reduced glutathione, activities of enzymes involved in glycolysis and Krebs cycle, protein synthesis, mitochondrial function, cellular proliferation, migration and viability. Our results demonstrate that high cN-II expression is associated with a glycolytic, highly proliferating phenotype, while silencing causes a reduction of proliferation, protein synthesis and migration ability, and an increase of oxidative performances. Similar results were obtained in a human astrocytoma cell line. Moreover, we demonstrate that cN-II silencing is concomitant with p53 phosphorylation, suggesting a possible involvement of this pathway in mediating some of cN-II roles in cancer cell biology.

SUBMITTER: Pesi R 

PROVIDER: S-EPMC6073589 | biostudies-literature | 2018 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Cytosolic 5'-Nucleotidase II Silencing in a Human Lung Carcinoma Cell Line Opposes Cancer Phenotype with a Concomitant Increase in p53 Phosphorylation.

Pesi Rossana R   Petrotto Edoardo E   Colombaioni Laura L   Allegrini Simone S   Garcia-Gil Mercedes M   Camici Marcella M   Jordheim Lars Petter LP   Tozzi Maria Grazia MG  

International journal of molecular sciences 20180720 7


Purine homeostasis is maintained by a purine cycle in which the regulated member is a cytosolic 5'-nucleotidase II (cN-II) hydrolyzing IMP and GMP. Its expression is particularly high in proliferating cells, indeed high cN-II activity or expression in hematological malignancy has been associated to poor prognosis and chemoresistance. Therefore, a strong interest has grown in developing cN-II inhibitors, as potential drugs alone or in combination with other compounds. As a model to study the effe  ...[more]

Similar Datasets

| S-EPMC4178970 | biostudies-literature
| S-EPMC1140532 | biostudies-literature
| S-EPMC2128783 | biostudies-literature
| S-EPMC8360054 | biostudies-literature
| S-EPMC2763634 | biostudies-literature
| S-EPMC3982195 | biostudies-literature
| S-EPMC4887848 | biostudies-literature
| S-EPMC7951108 | biostudies-literature
| S-EPMC3946280 | biostudies-literature
| S-EPMC9144445 | biostudies-literature